| Pharmaceutical active ingredients: |
| ChlorthalidoneDihydroergocristine MesylateMetipranolol |
| Available forms, composition and doses of Trimecryton: |
| N / A |
| Trimecryton medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C07BA68 - Metipranolol and thiazides, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Zentiva |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Clonidine; Chlorthalidone | Chlorthalidone; Clonidine Hydrochloride | Par Pharmaceutical |
| Clorpres | Chlorthalidone; Clonidine Hydrochloride | Mylan; Bertek Pharmaceuticals |
| Clothalton | Chlorthalidone; Clonidine Hydrochloride | Sarabhai Piramal Pharma |
| Combipres | Chlorthalidone; Clonidine Hydrochloride | Boehringer Ingelheim |
| Combipresan | Chlorthalidone; Clonidine Hydrochloride | Boehringer Ingelheim |
| Neocrystepin | Chlorthalidone; Dihydroergocristine Mesylate; Reserpine | Zentiva |
| Impresso | Chlorthalidone; Hydralazine Hydrochloride; Oxprenolol Hydrochloride | Alpharma |
| Impresso-Puren | Chlorthalidone; Hydralazine Hydrochloride; Oxprenolol Hydrochloride | Alpharma |
| Trepress | Chlorthalidone; Hydralazine Hydrochloride; Oxprenolol Hydrochloride | Novartis; Azupharma; Sandoz |
| Biotens | Chlorthalidone; Labetalol Hydrochloride | Kemyos Biomedical Research |